Pluristem Fast Forwards Placental Cell Therapy Into US-EU Pivotal Trial
Executive Summary
Off-the-shelf placental cell therapy for peripheral artery disease will move from Phase I to registration stage study in US and Europe in early 2017, following “positive feedback” from FDA.